Open Access Green as soon as Postprint is submitted to ZB.
Immune cells and metabolic dysfunction.
Semin. Immunopathol. 36, 13-25 (2014)
Throughout evolution, effective nutrient sensing and control of systemic energy homeostasis have relied on a close physical and functional interaction between immune and metabolically active cells. However, in today's obesogenic environment, this fine-tuned immunometabolic interface is perturbed. As a consequence, chronic inflammatory conditions and aberrant activation of immune cells have emerged as key features of obesity-related metabolic disorders, including insulin resistance, cardiovascular complications, and type 2 diabetes, whereas a major research focus has been placed on the adipocyte-macrophage interaction in the context of metabolic dysfunction; recent studies have not only expanded the scope of relevant immune cells in this setting but also highlight the impact of distinct metabolic organs, including the liver, on immunometabolic control, metabolic disease development, and potential anti-inflammatory therapeutic options in obesity-driven pathologies. This review will thus summarize recent progress in this emerging area of metabolic research.
Impact Factor
Scopus SNIP
Scopus
Cited By
Cited By
Altmetric
0.000
1.593
18
Annotations
Special Publikation
Hide on homepage
Publication type
Article: Journal article
Document type
Scientific Article
Language
english
Publication Year
2014
HGF-reported in Year
0
ISSN (print) / ISBN
1863-2297
Journal
Seminars in Immunopathology
Quellenangaben
Volume: 36,
Issue: 1,
Pages: 13-25
Publisher
Springer
Publishing Place
Berlin ; Heidelberg
Institute(s)
Institute of Diabetes and Cancer (IDC)
PubMed ID
24212254
Erfassungsdatum
2014-12-31